Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

NCT06647407 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Immunization
Healthy Volunteers

Interventions

BIOLOGICAL: Pentavalent Meningococcal ABCYW vaccine
BIOLOGICAL: MenACYW conjugate vaccine
BIOLOGICAL: MenACYW conjugate vaccine
BIOLOGICAL: Meningococcal group B vaccine
DRUG: Paracetamol
BIOLOGICAL: DTap-HepB-IPV-Hib vaccine
BIOLOGICAL: DTap-HepB-IPV-Hib vaccine
BIOLOGICAL: DTap-HepB-IPV-Hib vaccine
BIOLOGICAL: Rotavirus vaccine
BIOLOGICAL: Pneumococcal 13-valent conjugate vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company